Fourth doses are now being offered to vulnerable groups. But if you’re young and healthy, will you need one?
- Senior Lecturer in Immunology, Cardiff Metropolitan University
AstraZeneca’s durable monoclonal antibody treatment has shown promise in phase 3 clinical trials.
Two doses have always been more protective than one, but the delta variant has made the benefit of a second vaccine much greater.
Studi peneliti di Cambridge menemukan penanda darah yang dapat membantu memprediksi, sangat awal penyakit, yang akan mendapatkan COVID tingkat berat.
Cambridge study finds blood markers that could help predict, very early in the disease, who will get severe COVID.
Antibodies that go rogue and attack healthy tissue identified in patients with severe COVID.
Human Cytomegalovirus affects billions of people all around world so why haven’t most of us heard of it?
Contact Rebecca for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Website
- Article Feed
- ORCID
- Joined
